Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Pharmacovigilance.
These interactive and informal discussion groups are the hallmark of the meeting. Small exclusive groups of executive leaders who face shared challenges and strategic priorities are brought together in 60-minute sessions that enable participants to share ideas and lessons learned. Facilitated by experienced professionals, these sessions provide a valuable dialogue with peers on current challenges and topical issues. Each discussion group has limited numbers which ensures each delegate is given ample opportunity to raise questions and contribute to the discussion.